In mice with oxygen-induced retinopathy, modeling aberrant retinal vascular development, targeting mTOR activity through either rapamycin or VEGF-mediated signaling revealed that, in endothelial cells, the mTOR pathway is activated by VEGF. The gene discussed is VEGFA; the disease is retinal disorder.